PKM2, cancer metabolism, and the road ahead

EMBO Reports

Volumn 17, Issue 12, 2016, Pages 1721-1730

  Dayton, Talya L ^a   Jacks, Tyler ^a   Vander Heiden, Matthew G ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

cancer metabolism; glycolysis; PKM2; pyruvate kinase

Indexed keywords

PYRUVATE KINASE; PYRUVATE KINASE ISOFORM M1; PYRUVATE KINASE ISOFORM M2; UNCLASSIFIED DRUG; CARRIER PROTEIN; ISOENZYME; MEMBRANE PROTEIN; THYROID HORMONE; THYROID HORMONE-BINDING PROTEINS;

AEROBIC GLYCOLYSIS; CANCER CELL; CANCER GROWTH; CELL METABOLISM; ENZYME ACTIVITY; HUMAN; MOLECULAR BIOLOGY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL PROLIFERATION; GENETICS; GLYCOLYSIS; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; GLYCOLYSIS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; METABOLIC NETWORKS AND PATHWAYS; MICE; NEOPLASMS; PYRUVATE KINASE; THYROID HORMONES;

EID: 84999723809     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201643300     Document Type: Review

References (79)

1. Kops G, Weaver B, Cleveland D (2005) On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5: 773–785
2. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11: 325–337
3. Ferreira L, Hebrant A, Dumont JE (2012) Metabolic reprogramming of the tumor. Oncogene 31: 3999–4011
4. Ponder BA (2001) Cancer genetics. Nature 411: 336–341
5. Warburg O (1925) The metabolism of carcinoma cells. J Cancer Res 9: 148–163
6. Warburg O (1956) On the origin of cancer cells. Science 123: 309–314
7. Weinhouse S (1976) The Warburg hypothesis fifty years later. Z Krebsforsch Klin Onkol 87: 115–126
8. Jurica M, Mesecar A, Heath PJ, Shi W, Nowak T, Stoddard BL (1998) Structure 2: 195–210
9. Takenaka M, Yamada K, Lu T, Kang R, Tanaka T, Noguchi T (1996) Alternative splicing of the pyruvate kinase M gene in a minigene system. Eur J Biochem 235: 366–371
10. Noguchi T, Inoue H, Tanaka T (1986) The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem 261: 13807–13812
11. Dombrauckas JD, Santarsiero BD, Mesecar AD (2005) Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 44: 9417–9429
12. Garnett ME, Dyson RD, Dost FN (1974) Pyruvate kinase isozyme changes in parenchymal cells of regenerating rat liver. J Biol Chem 249: 5222–5226
13. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230–233
14. Dayton TL, Gocheva V, Miller KM, Israelsen WJ, Bhutkar A, Clish CB, Davidson SM, Luengo A, Bronson RT, Jacks T et al (2016) Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma. Genes Dev 30: 1020–1033
15. Mazurek S (2010) Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 43: 969–980
16. David CJ, Manley JL (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24: 2343–2364
17. Clower CV, Chatterjee D, Wang Z, Cantley LC, Vander Heiden MG, Krainer AR (2010) The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci USA 107: 1894–1899
18. Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC (2008) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452: 181–186
19. Cori CF (1983) Embden and the glycolytic pathway. Trends Biochem Sci 8: 257–259
20. Cori CF (1974) Some highlights of the early period of bioenergetics. Mol Cell Biochem 5: 47–53
21. Barnett JA (2003) A history of research on yeasts 5: the fermentation pathway. Yeast 20: 509–543
22. Zanella A, Fermo E, Bianchi P, Valentini G (2005) Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br J Haemotol 130: 11–25
23. Tanaka T, Harano Y, Morimura H, Mori R (1965) Evidence for the presence of two types of pyruvate kinase in rat liver. Biochem Biophys Res Commun 21: 55–60
24. Tanaka T, Harano Y, Sue F, Morimura H (1967) Crystallization, characterization and metabolic regulation of two types of pyruvate kinase isolated from rat tissues. J Biochem 62: 71–91
25. Susor WA, Rutter WJ (1968) Some distinctive properties of pyruvate kinase purified from rat liver. Biochem Biophys Res Commun 30: 14–20
26. Osterman J, Fritz PJ (1973) Pyruvate kinase isozymes: a comparative study in tissues of various mammalian species. Comp Biochem Physiol B 44: 1077–1085
27. Kamel R, Schwarzfischer F (1975) Pyruvate kinase isozyme patterns of human neoplastic, fetal and adult tissues. Humangenetik 28: 65–69
28. Peters J, Nash HR, Eicher EM, Bulfield G (1981) Polymorphism of kidney pyruvate kinase in the mouse is determined by a gene, Pk-3, on chromosome 9. Biochem Genet 19: 757–769
29. Peters J, Andrews SJ (1984) The Pk-3 gene determines both the heart, M1, and the kidney, M2, pyruvate kinase isozymes in the mouse; and a simple electrophoretic method for separating phosphoglucomutase-3. Biochem Genet 22: 1047–1063
30. Takenaka M, Noguchi T, Sadahiro S, Hirai H, Yamada K, Matsuda T, Imai E, Tanaka T (1991) Isolation and characterization of the human pyruvate kinase M gene. Eur J Biochem 198: 101–106
31. Guguen-Guillouzo C, Szajnert MF, Marie J, Delain D, Schapira F (1977) Differentiation in vivo and in vitro of pyruvate kinase isozymes in rat muscle. Biochimie 59: 65–71
32. Schneider J, Neu K, Velcovsky H-G, Morr H, Eigenbrodt E (2003) Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot study. Cancer Lett 193: 91–98
33. Ibsen KH, Orlando RA, Garratt KN, Hernandez AM, Giorlando S, Nungaray G (1982) Expression of multimolecular forms of pyruvate kinase in normal, benign, and malignant breast tissue. Cancer Research 42: 888–892
34. Farina FA, Shatton JB, Morris HP, Weinhouse S (1974) Isozymes of pyruvate kinase in liver and hepatomas of the rat. Cancer Res 34: 1439–1446
35. Farron F, Hsu HH, Knox WE (1972) Fetal-type isoenzymes in hepatic and nonhepatic rat tumors. Cancer Res 32: 302–308
36. Siwko S, Mochly-Rosen D (2007) Use of a novel method to find substrates of protein kinase C delta identifies M2 pyruvate kinase. Int J Biochem Cell Biol 39: 978–987
37. Hoshino A, Hirst JA, Fujii H (2007) Regulation of cell proliferation by interleukin-3-induced nuclear translocation of pyruvate kinase. J Biol Chem 282: 17706–17711
38. Yamada K, Noguchi T (1999) Nutrient and hormonal regulation of pyruvate kinase gene expression. Biochem J 337: 1–11
39. Pilkis SJ, El-Maghrabi MR (1988) Hormonal regulation of hepatic gluconeogenesis and glycolysis. Ann Rev Biochem 57: 755–783
40. +, and pyruvate. Biochemistry 33: 6301–6309
41. Ibsen KH (1977) Interrelationships and functions of the pyruvate kinase isozymes and their variant forms: a review. Cancer Res 37: 341–353
42. Ikeda Y, Tanaka T, Noguchi T (1997) Conversion of non-allosteric pyruvate kinase isozyme into an allosteric enzyme by a single amino acid substitution. J Biol Chem 272: 20495–20501
43. Israelsen WJ, Vander Heiden MG (2015) Pyruvate kinase: function, regulation and role in cancer. Semin Cell Dev Biol 43: 43–51
44. Ikeda Y, Noguchi T (1998) Allosteric regulation of pyruvate kinase M2 isozyme involves a cysteine residue in the intersubunit contact. J Biol Chem 273: 12227–12233
45. Yamada K, Noguchi T (1999) Regulation of pyruvate kinase M gene expression. Biochem Biophys Res Commun 256: 257–262
46. Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, Tempel W, Dimov S, Shen M, Jha A et al (2012) Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol 8: 839–847
47. Ashizawa K, McPhie P, Lin KH, Cheng SY (1991) An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1, 6-bisphosphate. Biochemistry 30: 7105–7111
48. Morgan HP, O'Reilly FJ, Wear MA, O'Neill JR, Fothergill Gilmore LA, Hupp T, Walkinshaw MD (2013) M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation. Proc Natl Acad Sci USA 110: 5881–5886
49. Keller KE, Tan IS, Lee YS (2012) SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. Science 338: 1069–1072
50. Williams R, Holyoak T, McDonald G, Gui C, Fenton A (2006) Differentiating a ligand's chemical requirements for allosteric interactions from those for protein binding. Phenylalanine inhibition of pyruvate kinase. Biochemistry 45: 5421–5429
51. Hitosugi T, Kang S, Vander Heiden MG, Chung T-W, Elf S, Lythgoe K, Dong S, Lonial S, Wang X, Chen GZ et al (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2: ra73
52. Presek P, Reinacher M, Eigenbrodt E (1988) Pyruvate kinase type M2 is phosphorylated at tyrosine residues in cells transformed by Rous sarcoma virus. FEBS Lett 242: 194–198
53. Keller KE, Doctor ZM, Dwyer ZW, Lee Y-S (2014) SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells. Mol Cell 53: 700–709
54. Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H, Zha Z, Liu Y, Li Z, Xu Y et al (2011) Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 42: 719–730
55. Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang J-K, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS et al (2011) Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334: 1278–1283
56. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R (1992) Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog 3: 91–115
57. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R (1992) Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog 3: 91–115
58. Kung C, Hixon J, Choe S, Marks K, Gross S, Murphy E, Delabarre B, Cianchetta G, Sethumadhavan S, Wang X et al (2012) Small molecule activation of PKM2 in cancer cells induces serine auxotrophy. Chem Biol 19: 1187–1198
59. Chaneton B, Hillmann P, Zheng L, Martin AC, Maddocks OD, Chokkathukalam A, Coyle JE, Jankevics A, Holding FP, Vousden KH et al (2012) Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491: 458–462
60. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK et al (2011) Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476: 346–350
61. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H et al (2011) Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43: 869–874
62. Kalhan SC, Hanson RW (2012) Resurgence of serine: an often neglected but indispensable amino Acid. J Biol Chem 287: 19786–19791
63. Maddocks ODK, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, Vousden KH (2013) Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493: 542–546
64. DeNicola GM, Chen P-H, Mullarky E, Sudderth JA, Hu Z, Wu D, Tang H, Xie Y, Asara JM, Huffman KE et al (2015) NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat Genet 47: 1475–1481
65. Olson KA, Schell JC, Rutter J (2016) Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies. Trends Biochem Sci 41: 219–230
66. Luo W, Hu H, Chang R, Zhong J, Knabel M, O'meally R, Cole RN, Pandey A, Semenza GL (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145: 732–744.
67. Wang H-J, Hsieh Y-J, Cheng W-C, Lin C-P, Lin Y-S, Yang S-F, Chen C-C, Izumiya Y, Yu J-S, Kung H-J et al (2014) JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism. Proc Natl Acad Sci USA 111: 279–284
68. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, Gao X, Aldape K, Lu Z (2011) Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature 480: 118–122
69. Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, Lyssiotis CA, Aldape K, Cantley LC, Lu Z (2012) ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol 14: 1295–1304
70. Gao X, Wang H, Yang JJ, Liu X, Liu Z-R (2012) Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 45: 598–609
71. Gao X, Wang H, Yang JJ, Chen J, Jie J, Li L, Zhang Y, Liu Z-R (2013) Reciprocal regulation of protein kinase and pyruvate kinase activities of pyruvate kinase M2 by growth signals. J Biol Chem 288: 15971–15979
72. Jiang Y, Wang Y, Wang T, Hawke DH, Zheng Y, Li X, Zhou Q, Majumder S, Bi E, Liu DX et al (2014) PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells. Nat Commun 5: 5566
73. Jiang Y, Li X, Yang W, Hawke DH, Zheng Y, Xia Y, Aldape K, Wei C, Guo F, Chen Y et al (2014) PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol Cell 53: 75–87
74. Israelsen WJ, Dayton TL, Davidson SM, Fiske BP, Hosios AM, Bellinger G, Li J, Yu Y, Sasaki M, Horner JW et al (2013) PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155: 397–409
75. Wang Y-H, Israelsen WJ, Lee D, Yu VWC, Jeanson NT, Clish CB, Cantley LC, Vander Heiden MG, Scadden DT (2014) Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell 158: 1309–1323
76. Hosios AM, Fiske BP, Gui DY, Vander Heiden MG (2015) Lack of evidence for PKM2 protein kinase activity. Mol Cell 59: 850–857
77. Lunt SY, Muralidhar V, Hosios AM, Israelsen WJ, Gui DY, Newhouse L, Ogrodzinski M, Hecht V, Xu K, Acevedo PNM et al (2015) Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol Cell 57: 95–107
78. Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MAR, Sheedy FJ, Gleeson LE, van den Bosch MWM, Quinn SR, Domingo-Fernandez R, Johnston DGW et al (2015) Pyruvate kinase M2 regulates hif-1alpha; activity and IL-1beta; induction and is a critical determinant of the Warburg effect in LPS-activated macrophages. Cell Metab 21: 65–80
79. Lochmatter C, Fischer R, Charles PD, Yu Z, Powrie F, Kessler BM (2016) Integrative phosphoproteomics links IL-23R signaling with metabolic adaptation in lymphocytes. Sci Rep 6: 24491